Pfizer agrees to slash prescription drug prices for Americans
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
India currently hosts more than 10,075 biotech startups
The platform is being introduced to expand access to treatments for people living with chronic conditions
Miels will formally assume the role on January 1, 2026
The Hub & Spoke model is designed to extend advanced medical care to a wider community
LEQEMBI was initially approved in China in January 2024 for the treatment of Alzheimer’s disease in patients with mild cognitive impairment
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Subscribe To Our Newsletter & Stay Updated